ACO Name and Location

Emerald Coast ACO, LLC
1005 Mar Walt Drive
Fort Walton Beach, Florida 32547

 

ACO Primary Contact

Primary Contact Name

Mark Wiacek

 

Primary Contact Phone Number

850-863-8250

 

Primary Contact Email Address

mwiacek@white-wilson.com

 

 

Organizational Information

ACO participants:

ACO Participants

ACO Participant in Joint Venture (Enter Y or N)

White Wilson Medical Center Pa

N

 

 

ACO governing body:

Member

Member's Voting Power

Membership Type

ACO Participant TIN Legal Business Name/DBA, if Applicable

Last Name

First Name

Title/Position

Gleseman

Alan

Chariman

1

Community Stakeholder Representative

N/A

Loder, MD

Dr. Andrea

Medical Director

1

ACO Participant Representative

White Wilson Medical Center Pa

Krist, MD

Dr. Keith

Board Member

1

ACO Participant Representative

White Wilson Medical Center Pa

Hansen, MD

Dr. Chrstopher

Board Member

1

ACO Participant Representative

White Wilson Medical Center Pa

Van, MD

Dr. Chinh

Board Member

1

ACO Participant Representative

White Wilson Medical Center Pa

Aubert, MD

Dr. Fred

Board Member

1

ACO Participant Representative

White Wilson Medical Center Pa

Androssov, MD

Dr. Andrei

Board Member

1

ACO Participant Representative

White Wilson Medical Center Pa

Brown, MD

Dr. Gil

Board Member

1

ACO Participant Representative

White Wilson Medical Center Pa

Weiner, MD

Dr. Hilton

Board Member

1

ACO Participant Representative

White Wilson Medical Center Pa

Fischer, MD

Dr. Melissa

Board Member

1

ACO Participant Representative

White Wilson Medical Center Pa

Wiacek

Mark

Board Member

1

ACO Executive

N/A

 

 

Key ACO clinical and administrative leadership:

Mark Wiacek

ACO Executive

Dr. Andrea Loder, M.D.

Medical Director

Dr. Ken Persuad, MD

Compliance Officer

Dr. Keith Krist, MD

Quality Assurance/Improvement Officer

 

 

 

Associated committees and committee leadership:

Committee Name

Committee Leader Name and Position

Health Information Committee

Mark Wiacek, Chair

Patient Advisory Committee

Dr. Andrea Loder, MD, Medcial Director/Chair

Peer Review and Quality Assurance Committee

Dr. Keith Krist, MD, Chair

 

Types of ACO participants, or combinations of participants, that formed the ACO:

 

Shared Savings and Losses

Amount of Shared Savings/Losses

 

Shared Savings Distribution

 

Quality Performance Results

2016 Quality Performance Results:

ACO#

Measure Name

Rate

ACO Mean

ACO-1

CAHPS: Getting Timely Care, Appointments, and Information

N/A

80.51

ACO-2

CAHPS: How Well Your Providers Communicate

N/A

93.01

ACO-3

CAHPS: Patients’ Rating of Provider

N/A

92.25

ACO-4

CAHPS: Access to Specialists

N/A

83.49

ACO-5

CAHPS: Health Promotion and Education

N/A

60.32

ACO-6

CAHPS: Shared Decision Making

N/A

75.40

ACO-7

CAHPS: Health Status/Functional Status

N/A

72.30

ACO-34

CAHPS: Stewardship of Patient Resources

N/A

26.97

ACO-8

Risk Standardized, All Condition Readmission

N/A

14.70

ACO-35

Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM)

N/A

18.17

ACO-36

All-Cause Unplanned Admissions for Patients with Diabetes

N/A

53.20

ACO-37

All-Cause Unplanned Admissions for Patients with Heart Failure

N/A

75.23

ACO-38

All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions

N/A

59.81

ACO-9

Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)

N/A

9.27

ACO-10

Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8)

N/A

14.53

ACO-11

Percent of PCPs who Successfully Meet Meaningful Use Requirements

N/A

82.72

ACO-39

Documentation of Current Medications in the Medical Record

N/A

87.54

ACO-13

Falls: Screening for Future Fall Risk

N/A

64.04

ACO-14

Preventive Care and Screening: Influenza Immunization

N/A

68.32

ACO-15

Pneumonia Vaccination Status for Older Adults

N/A

69.21

ACO-16

Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up

N/A

74.45

ACO-17

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

N/A

90.98

ACO-18

Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan

N/A

53.63

ACO-19

Colorectal Cancer Screening

N/A

61.52

ACO-20

Breast Cancer Screening

N/A

67.61

ACO-21

Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented

N/A

76.79

ACO-42

Statin therapy for the Prevention and Treatment of Cardiovascular Disease

N/A

77.72

ACO-27

Diabetes Mellitus: Hemoglobin A1c Poor Control

N/A

18.24

ACO-41

Diabetes: Eye Exam

N/A

44.94

ACO-28

Hypertension (HTN): Controlling High Blood Pressure

N/A

70.69

ACO-30

Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic

N/A

85.05

ACO-31

Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

N/A

88.67

ACO-33

Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)

N/A

79.67

 

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

 

 

Payment Rule Waivers

·         No, our ACO does not use the SNF 3-Day Rule Waiver.

 

 

For general questions or additional information about Accountable Care Organizations, please visit www.cms.gov and do a search using that term, or call 1-800 MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048